National and Kapodistrian University of Athens
Molecular mechanisms of hepatocellular carcinoma
Abstract
dc:descriptionThe liver, a vital organ performing essential functions, such as bile production and protein synthesis, is susceptible to severe diseases, including Hepatocellular Carcinoma (HCC), which constitutes ~80% of primary liver cancers. HCC frequently arises in the context of chronic inflammation and exhibits poor prognosis due to limited therapeutic efficacy. Invariant Natural Killer T (iNKT) cells, a specialized lymphocyte subset enriched in the liver, play a dual role in carcinogenesis, potentially enhancing or suppressing tumor progression. These cells exhibit strong antitumor activity through cytotoxic mechanisms and modulation of the tumor microenvironment, making them promising targets for immunotherapy.This PhD thesis investigated the role of iNKT cells in HCC progression using mouse models genetically engineered to either lack or overproducing iNKT cells. Using diethylnitrosamine (DEN)-induced HCC, we examined iNKT cell dynamics, cytokine production, and transcriptomic changes. The study revealed that iNKT cells were significantly reduced in HCC due to apoptosis, with compromised cytokine production impairing their antitumor functions. Interestingly, iNKT cell deficiency mitigated liver damage during early HCC development but promoted immunosuppression and tumor proliferation in later stages. Adoptive transfer of healthy iNKT cells reduced tumor burden in advanced HCC, suggesting stage-specific therapeutic potential.The study also explores the functions of the epigenetic regulator Smyd2, a lysine methyltransferase implicated in cancer. Smyd2 depletion in iNKT cells revealed its critical role in sustaining activation, cytokine production, and mitochondrial integrity. Smyd2-deficient iNKT cells exhibited impaired immune responses due to mitochondrial dysfunction and altered TCR signaling pathways.These findings underscore the complexity of iNKT cell functions in HCC and highlight Smyd2 as a key regulator of iNKT cell-mediated immunity. This work contributes to understanding iNKT cell biology and provides insights into novel immunotherapeutic strategies targeting HCC.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papanastasatou, Maria
- Παπαναστασάτου, Μαρία
Subjects
dc:subject × 15- Φυσικά φονικά Τ κύτταρα
- Ηπατοκυτταρικό καρκίνωμα
- Smyd2
- Μιτοχόνδριο
- Ανοσο-ογκολογία
- Invariant natural killer T lymphocytes
- Hepatocellular carcinoma
- Mitochondrion
- Immuno-oncology
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, γενικά
- Health Sciences
- Medical and Health Sciences
- Health sciences, general
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61788